Compound Evidence File
#EC-2026-0976
Hexarelin
Filed under Peptides. The bureau holds 51 laboratory returns for this compound from 20 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
20 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 10.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 8.9 | 8.2 | 9.6 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.6 | 6.2 | 10.0 | 21 May 2026 | 21 May 2026 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 8.4 | 8.4 | 8.4 | 28 Mar 2025 | 28 Mar 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.3 | 7.0 | 9.2 | 25 May 2026 | 25 May 2026 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 8.3 | 8.3 | 8.3 | 8 Jul 2025 | 8 Jul 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.1 | 7.6 | 8.5 | 21 May 2026 | 21 May 2026 |
| Reta-PeptideCASE #VI-2026-0756 | X | 3 | 8.1 | 7.0 | 9.2 | 24 Apr 2025 | 20 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 3 | 7.9 | 6.3 | 10.0 | 13 Jun 2025 | 19 Jan 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 7.5 | 7.1 | 7.9 | 23 May 2026 | 23 May 2026 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 5 | 7.0 | 5.5 | 8.4 | 11 Jun 2025 | 24 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 6.8 | 6.8 | 6.8 | 3 Jul 2025 | 3 Jul 2025 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 5.8 | 5.8 | 5.8 | 2 Apr 2025 | 2 Apr 2025 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 | 13 Jun 2025 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 5.1 | 5.1 | 5.1 | 28 Mar 2025 | 28 Mar 2025 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 4.9 | 4.9 | 4.9 | 9 Jun 2025 | 9 Jun 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 4.7 | 4.7 | 4.7 | 8 Jul 2025 | 8 Jul 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 4.5 | 4.5 | 4.5 | 2 Jul 2025 | 2 Jul 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 3.6 | 3.6 | 3.6 | 28 Mar 2025 | 28 Mar 2025 |
Open any subject to view the batch-level evidence for Hexarelin alone.